HK1125926A1 - Pyrrole derivatives with histone deacetylase inhibitor activity - Google Patents

Pyrrole derivatives with histone deacetylase inhibitor activity

Info

Publication number
HK1125926A1
HK1125926A1 HK09104096.6A HK09104096A HK1125926A1 HK 1125926 A1 HK1125926 A1 HK 1125926A1 HK 09104096 A HK09104096 A HK 09104096A HK 1125926 A1 HK1125926 A1 HK 1125926A1
Authority
HK
Hong Kong
Prior art keywords
histone deacetylase
deacetylase inhibitor
inhibitor activity
pyrrole derivatives
pyrroles
Prior art date
Application number
HK09104096.6A
Other languages
English (en)
Inventor
Mora Fernando Pedro Cossio
Badosa Manel Esteller
Olascoaga Aizpea Zubia
Ansa Dorleta Otaegui
Original Assignee
Univ Pais Vasco
Ct Nac Investigaciones Oncologicas Cnio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pais Vasco, Ct Nac Investigaciones Oncologicas Cnio filed Critical Univ Pais Vasco
Publication of HK1125926A1 publication Critical patent/HK1125926A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/42—Nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK09104096.6A 2005-12-27 2009-05-04 Pyrrole derivatives with histone deacetylase inhibitor activity HK1125926A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES2005/000708 WO2007074176A1 (es) 2005-12-27 2005-12-27 Nuevos derivados pirrólicos con actividad inhibidora de desacetilasas de histonas

Publications (1)

Publication Number Publication Date
HK1125926A1 true HK1125926A1 (en) 2009-08-21

Family

ID=38217700

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09104096.6A HK1125926A1 (en) 2005-12-27 2009-05-04 Pyrrole derivatives with histone deacetylase inhibitor activity

Country Status (18)

Country Link
US (1) US7638550B2 (pt)
EP (1) EP1975158B9 (pt)
JP (1) JP4975758B2 (pt)
CN (1) CN101351444B (pt)
AT (1) ATE516268T1 (pt)
AU (1) AU2005339535B2 (pt)
BR (1) BRPI0520806A2 (pt)
CA (1) CA2635392C (pt)
CY (1) CY1111899T1 (pt)
DK (1) DK1975158T3 (pt)
ES (1) ES2369705T3 (pt)
HK (1) HK1125926A1 (pt)
MX (1) MX2008008470A (pt)
PL (1) PL1975158T3 (pt)
PT (1) PT1975158E (pt)
RU (1) RU2416600C2 (pt)
SI (1) SI1975158T1 (pt)
WO (1) WO2007074176A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090298905A1 (en) * 2005-04-15 2009-12-03 Fernando Pedro Cossio Nitrogenatd trans-stilbene analogs, method for the obtention and medical applications thereof
EP2305643A1 (en) * 2009-10-02 2011-04-06 Ikerchem, S.L. New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers
EP2508510A1 (en) * 2011-04-06 2012-10-10 Ikerchem, S.L. Hydroxyphenyl pyrrole compounds containing an hydroxamic acid as hdac inhibitors and medicinal applications thereof
CN103373969B (zh) * 2012-04-27 2015-09-16 中国科学院上海有机化学研究所 苯基唑环取代酰胺类化合物及其制备方法和用途
AU2016267872B2 (en) * 2015-05-22 2019-01-17 Chong Kun Dang Pharmaceutical Corp. Heterocyclicalkyl derivative compounds as selective histone deacetylase inhibitors and pharmaceutical compositions comprising the same
CN106565583A (zh) * 2016-11-15 2017-04-19 淮阴师范学院 多取代吡咯衍生物的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2273836A1 (en) * 1996-12-10 1998-06-18 G.D. Searle & Co. Substituted pyrrolyl compounds for the treatment of inflammation
JP4191825B2 (ja) * 1998-09-10 2008-12-03 あすか製薬株式会社 ５−アミノイソキサゾール誘導体
KR20020059393A (ko) * 1999-09-08 2002-07-12 제임스 에스. 쿼크 새로운 부류의 세포분화제 및 히스톤 데아세틸라아제, 및이의 사용 방법
DK1335898T3 (da) * 2000-09-29 2006-04-03 Topotarget Uk Ltd Carbaminsyreforbindelser omfattende en amidbinding som HDAC-inhibitorer
US6576612B1 (en) * 2000-10-02 2003-06-10 Pharmacia Italia S.P.A. Antitumor therapy comprising distamycin derivatives
US7612064B2 (en) 2003-05-26 2009-11-03 Takeda Pharmaceutical Company Limited Sulfopyrroles
EP1691803A1 (en) 2003-12-05 2006-08-23 Warner-Lambert Company LLC N-alkyl pyrroles as hmg-coa reductase inhibitors
EP1725528B1 (en) * 2004-03-11 2013-05-29 4Sc Ag Sulphonylpyrroles as hdac inhibitors

Also Published As

Publication number Publication date
JP4975758B2 (ja) 2012-07-11
CY1111899T1 (el) 2015-11-04
CN101351444B (zh) 2011-07-13
ES2369705T3 (es) 2011-12-05
SI1975158T1 (sl) 2011-10-28
MX2008008470A (es) 2008-09-26
EP1975158B9 (en) 2012-02-29
DK1975158T3 (da) 2011-10-24
US7638550B2 (en) 2009-12-29
EP1975158B1 (en) 2011-07-13
AU2005339535A1 (en) 2007-07-05
JP2009521519A (ja) 2009-06-04
RU2008130876A (ru) 2010-02-10
RU2416600C2 (ru) 2011-04-20
PL1975158T3 (pl) 2011-12-30
BRPI0520806A2 (pt) 2009-06-09
EP1975158A1 (en) 2008-10-01
ATE516268T1 (de) 2011-07-15
WO2007074176A1 (es) 2007-07-05
PT1975158E (pt) 2011-09-23
CN101351444A (zh) 2009-01-21
EP1975158A4 (en) 2009-11-11
US20080262073A1 (en) 2008-10-23
CA2635392A1 (en) 2007-07-05
CA2635392C (en) 2013-07-23
AU2005339535B2 (en) 2012-02-23

Similar Documents

Publication Publication Date Title
WO2007109178A3 (en) Indole derivatives as inhibitors of histone deacetylase
EA201270215A1 (ru) Apaf-1 ингибиторные соединения
EA200970447A1 (ru) Соединения и композиции в качестве ингибиторов протеинкиназы
MY144970A (en) Heterocyclic compounds
EA201170531A1 (ru) Соединения на основе пиридина и пиримидина в качестве ингибиторов сигнального пути wnt для лечения рака
WO2006106326A8 (en) Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
MX2009006706A (es) Compuestos heterociclicos biciclicos como inhibidores del receptor del factor de crecimiento de fibroblastos.
WO2010009139A3 (en) Imidazolylpyrimidine compounds as hdac and / or cdk inhibitors
MX2009006704A (es) Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa.
MY149957A (en) Heterocyclic inhibitors of mek and methods of use thereof
GEP20146060B (en) Pyridyl inhibitors of hedgehog signalling
EA201300684A1 (ru) Производные 6-амино-2-фениламино-1н-бензимидазол-5-карбоксамида и их применение в качестве ингибиторов микросомной простагландин-е2-синтазы-1
WO2010011296A3 (en) Deacetylase inhibitors and uses thereof
CL2007003495A1 (es) Compuestos derivados de heterociclos condensados sustituidos, inhibidores de la actividad de la akt; composicion farmaceutica; y uso para el tratamiento o prevencion del cancer.
WO2007095124A3 (en) Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
TW200736229A (en) Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
MY142589A (en) Benzimidazole derivatives : preparation and pharmaceutical applications
EA200900798A1 (ru) Производные индол-4-илпиримидинил-2-иламина и их применение в качестве ингибиторов циклинзависимой киназы
WO2006063294A3 (en) Novel inhibitors of histone deacetylase for the treatment of disease
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
BRPI0410727A (pt) composto, composição farmacêutica, e, uso de um composto
WO2005086656A3 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
WO2009030952A3 (en) Phenylcarboxamide derivatives as inhibitors and effectors of the hedgehog pathway
EP2142549A4 (en) ADENOSINE DERIVATIVES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES THEREOF CONTAINING THEM AS AN ACTIVE SUBSTANCE

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20151227